Share this video  

NCRI 2019 | HER-2 conversion: a phenomenon in trastuzumab resistance

Russell Petty, BMSC, MB ChB, PhD, MRCP, University of Dundee, Dundee, UK, talks about precision cancer biology and the phenomenon of HER-2 conversion that occurs in trastuzumab resistance. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter